Concepedia

Seleeke Flingai

SF

10

Publications

637

Citations

10

H-Index

2013

Active since

Affiliations

Inovio Pharmaceuticals (United States)(Current)

University of Pennsylvania

University of South Florida

The Wistar Institute

Seleeke Flingai is an author at Inovio Pharmaceuticals (United States) specializing in immunology, immunotherapy, and medicine.

Top concepts

Publications per year

2013–2018

10

Publications

10

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

Kar Muthumani, Darryl Falzarano, Emma L. Reuschel et al. · Science Translational Medicine · 2015 · 249 citations · Full text

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus

Kar Muthumani, Peter D. Block, Seleeke Flingai et al. · The Journal of Infectious Diseases · 2016 · 84 citations · Full text

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy

Seleeke Flingai, Emily M. Plummer, Ami Patel et al. · Scientific Reports · 2015 · 71 citations · Full text

An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model

Ami Patel, Antonio DiGiandomenico, Ashley Keller et al. · Nature Communications · 2017 · 63 citations · Full text

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections

Sarah T. C. Elliott, Nicole L. Kallewaard, Ebony Benjamin et al. · npj Vaccines · 2017 · 48 citations · Full text

Rows per page

1–5 of 10